Organ distribution of 5-fluorouracil loaded gelatine microspheres in mice

被引:0
|
作者
Hao, XH
Gang, C
Zou, MJ
Jin, S
Cui, FD
机构
[1] Shenyang Pharmaceut Univ, Dept Pharmaceut, Sch Pharm, Shenyang 110016, Peoples R China
[2] Jilin Univ, Changchun 130023, Peoples R China
来源
PHARMAZIE | 2004年 / 59卷 / 09期
关键词
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The aim of this study was to investigate the organ distribution characteristics of 5-fluorouracil (5-Fu) loaded crosslinked gelatine microspheres (5-Fu-MS) after intravenous (i.v.) injection compared to 5-Fu solution in mice, and to evaluate the targetability of 5-Fu-MS. The concentrations of 5-Fu in mice plasma, heart, liver, lung, kidney, spleen and brain were determined by HPLC. The parameters drug targeting index C-e, time-averaged relative drug exposure values r(e), drug targeting efficiency t(e), and drug distributed to target-tissue (%) were used to evaluate the targetability of the 5-Fu-MS delivery system. The results showed that the concentration of 5-Fu in the lung was significantly higher than after application of 5-Fu solution, and that the maximum concentration of 5-Fu, 72.8 mug (.) g organ(-1), was reached in the lung at 15 min after i.v. administration. As for 5-Fu-MS, r(e) was calculated to be 2.2, and t(e) was considerably higher than after application of 5-Fu in solution. Furthermore, the percentage of drug distributed to the lung was 2 times as high as after application in solution. Accordingly, 5-Fu-MS were capable of effectively delivering 5-Fu to the lung and possessed specific targetability towards the lung compared to 5-Fu solution.
引用
收藏
页码:709 / 712
页数:4
相关论文
共 50 条
  • [21] Pharmacokinetics and tissue distribution of 5-fluorouracil encapsulated by galactosylceramide liposomes in mice
    Jin, Y
    Li, J
    Rong, LF
    Lü, XW
    Huang, Y
    Xu, SY
    ACTA PHARMACOLOGICA SINICA, 2005, 26 (02) : 250 - 256
  • [22] Preparation and properties of biodegradable microspheres containing 5-fluorouracil
    Yin, Jing-Bo
    Chen, Hong-Dan
    Luo, Kun
    Zhuang, Xiu-Li
    Chen, Xue-Si
    Cao, Tian
    Gaodeng Xuexiao Huaxue Xuebao/Chemical Journal of Chinese Universities, 2005, 26 (06): : 1174 - 1176
  • [23] Examination of the ovotoxicity of 5-fluorouracil in mice
    Lambouras, M.
    Liew, S. H.
    Horvay, K.
    Abud, H. E.
    Stringer, J. M.
    Hutt, Karla J.
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2018, 35 (06) : 1053 - 1060
  • [24] Examination of the ovotoxicity of 5-fluorouracil in mice
    M. Lambouras
    S. H. Liew
    K. Horvay
    H. E. Abud
    J. M. Stringer
    Karla J. Hutt
    Journal of Assisted Reproduction and Genetics, 2018, 35 : 1053 - 1060
  • [25] PREPARATION AND CHARACTERIZATION OF ETHYLCELLULOSE MICROSPHERES CONTAINING 5-FLUOROURACIL
    ZINUTTI, C
    KEDZIEREWICZ, F
    HOFFMAN, M
    MAINCENT, P
    JOURNAL OF MICROENCAPSULATION, 1994, 11 (05) : 555 - 563
  • [26] Preparation and properties of biodegradable microspheres containing 5-fluorouracil
    Yin, JB
    Chen, HD
    Luo, K
    Zhuang, XL
    Chen, XS
    Cao, T
    CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2005, 26 (06): : 1174 - 1176
  • [27] BINDING OF 5-FLUOROURACIL TO MICROSPHERES STARCH-PARTICLES
    CZEJKA, M
    SCHULLER, J
    ARCHIV DER PHARMAZIE, 1991, 324 (01) : 53 - 53
  • [28] Liquid crystalline microspheres for 5-fluorouracil specific release
    Cassano, Roberta
    Nicoletta, Fiore Pasquale
    Mellace, Silvia
    Grande, Fedora
    Picci, Nevio
    Trombino, Sonia
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2017, 41 : 482 - 487
  • [29] In-vitro Characterization and Cytotoxicity Analysis of 5-Fluorouracil loaded Chitosan Microspheres for Targeting Colon Cancer
    Kaushik, Dinesh
    Sardana, Satish
    Mishra, DinaNath
    INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2010, 44 (03) : 274 - 282
  • [30] 5-Fluorouracil loaded Eudragit fibers prepared by electrospinning
    Illangakoon, U. Eranka
    Yu, Deng-Guang
    Ahmad, Bilal S.
    Chatterton, Nicholas P.
    Williams, Gareth R.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 495 (02) : 895 - 902